Yahoo · Sep 29, 2026
IART or PEN: Which Is the Better Value Stock Right Now?
IART vs. PEN: Which Stock Is the Better Value Option?
NASDAQ · IART
Integra LifeSciences Holdings Corporation
Healthcare · Medical - Devices
$16.09
Down-$3.41 (-21.19%)
Updated Oct 2, 2026, 10:28 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.1B
- P/E ratio
- -2.18
- Dividend yield
- 0.00%
- 52-week range
- $8.70 – $20.49
- Volume
- 652.94K
- Avg. volume
- 1.05M
Price performance · IART
IART price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
IART closed at $16.09 after 20 trading sessions, down 2.13% for the selected period.
- Last close
- $16.09
- Period change
- -2.13%
- Period low
- $15.10
- Period high
- $16.72
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $16.21 | $16.45 | $15.88 | $16.09 | 652.94K |
| Sep 30, 2026 | $16.67 | $16.67 | $16.14 | $16.28 | 768.91K |
| Sep 29, 2026 | $16.27 | $16.765 | $15.80 | $16.64 | 1.01M |
| Sep 28, 2026 | $16.04 | $16.27 | $15.86 | $16.27 | 479.05K |
| Sep 25, 2026 | $15.88 | $16.21 | $15.74 | $16.12 | 539.03K |
| Sep 24, 2026 | $15.67 | $15.91 | $15.49 | $15.88 | 759.53K |
| Sep 23, 2026 | $15.88 | $16.26 | $15.38 | $15.53 | 573.08K |
| Sep 22, 2026 | $15.90 | $16.285 | $15.69 | $16.02 | 770.45K |
| Sep 21, 2026 | $15.06 | $15.65 | $14.91 | $15.59 | 1.06M |
| Sep 18, 2026 | $14.98 | $15.24 | $14.875 | $15.22 | 2.17M |
| Sep 17, 2026 | $16.30 | $16.375 | $15.07 | $15.10 | 1.05M |
| Sep 16, 2026 | $15.81 | $16.22 | $15.65 | $16.06 | 1.62M |
| Sep 15, 2026 | $15.69 | $16.035 | $15.20 | $15.69 | 1.08M |
| Sep 14, 2026 | $15.36 | $15.80 | $15.36 | $15.71 | 1.14M |
| Sep 11, 2026 | $16.06 | $16.22 | $15.33 | $15.50 | 792.03K |
| Sep 10, 2026 | $15.93 | $16.035 | $15.3878 | $15.54 | 1.36M |
| Sep 9, 2026 | $16.10 | $16.46 | $15.99 | $16.25 | 578.4K |
| Sep 8, 2026 | $16.48 | $16.5498 | $15.985 | $16.26 | 621.8K |
| Sep 4, 2026 | $16.32 | $16.78 | $16.25 | $16.72 | 674.91K |
| Sep 3, 2026 | $17.09 | $17.11 | $16.28 | $16.44 | 998.47K |
Latest IART news
The latest Smart Investors Daily articles mentioning IART.
Stock researchCompany · Overview
Company
Market Activity
Research & News
IART research
Overview
Company profile and research snapshot.
Company profile
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $15.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 28, 2026 | UBS | Neutral | — |
| Jul 16, 2026 | Truist Securities | Hold | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jul 8, 2026 | Citigroup | Neutral | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 29, 2026
Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry
Prospective, multicenter registry advances toward planned enrollment of 300 pediatric patients ACCLARENT AERA® Eustachian Tube Balloon Dilation System ACCLARENT AERA® Eustachian Tube Balloon Dilation System PRINCETON, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences (Nasdaq: IART), a leading global medical technology company, announced today the enrollment of the 100th patient in the AERA® Pediatric Registry, a prospective, multicenter observational registry evaluating the real-worl
Benzinga · Sep 29, 2026
Integra LifeSciences Enrolls 100th Participant In Its AERA Pediatric Registry Observational Registry
Integra LifeSciences (Nasdaq: IART), a leading global medical technology company, announced today the enrollment of the 100th patient in the AERA® Pediatric Registry, a prospective, multicenter observational registry
Yahoo · Sep 28, 2026
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
